BeStock  
Stocks › RPRX

Royalty Pharma RPRX

US equityMarket cap rank #488
$57.39 −$0.97 (-1.66%)
Market open · Oct 1, 12:40 pm ET · After hours $58.36 0.00%
Open$58.36
Prev close$58.36
Day range$57.37 – $58.40
Volume896.7K
Market cap$25.55B
P/E (TTM)30.9
Dividend yield1.59%

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$674.14M+16.5% YoY
Operating profit$133.12M-36.5% YoY
Net profit$81.49M-12.0% YoY
Diluted EPS$0.04-42.9% YoY
Free cash flow$728.46M+100.1% YoY
Operating cash flow$728.46M

Revenue, last 8 quarters

$564.7MSep '24$593.6MDec '24$568.2MMar '25$578.7MJun '25$609.3MSep '25$622.0MDec '25$630.6MMar '26$674.1MJun '26

Net profit, last 8 quarters

$806.4MSep '24$334.4MDec '24$434.4MMar '25$92.6MJun '25$444.2MSep '25$355.9MDec '25$468.3MMar '26$81.5MJun '26

Diluted EPS by quarter

1.21Sep '240.35Dec '240.55Mar '250.07Jun '250.67Sep '250.38Dec '250.67Mar '260.04Jun '26

Free cash flow by quarter

$703.6MSep '24$742.5MDec '24$596.1MMar '25$364.0MJun '25$702.6MSep '25$827.1MDec '25$718.2MMar '26$728.5MJun '26

Annual revenue

$2.1BFY20$2.3BFY21$2.2BFY22$2.4BFY23$2.3BFY24$2.4BFY25

Profitability & balance sheet

Operating margin62.3%
Net margin32.0%
Return on equity12.3%
Return on assets4.3%
Return on invested capital7.6%
Current ratio2.80
Liabilities / assets50.6%
Cash & investments$1.73B
Total debt$8.96B
Net cash (debt)-$7.24B
Free cash flow / sales117.4%

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Revenue as Reported $674.14M – $2.38B $621.99M $609.29M
Total Operating Revenue $674.14M $630.58M $2.38B $621.99M $609.29M
Operating Expense $541.02M -$1.91M $818.68M $233.61M $182.14M
Selling and Admin Expenses $161.89M $159.49M $573.48M $164.27M $118.73M
-General & Admin Expense $161.89M $159.49M $573.48M $164.27M $118.73M
Research & Development $97.85M $39.79M $452.00M $50.50M $50.50M
Asset Impairment Loss $13.07M -$3.70M $89.03M -$4.27M $766,000.00
Other Operating Expenses $268.22M -$197.49M -$295.84M $23.11M $12.14M
Operating Profit $133.12M $632.48M $1.56B $388.38M $427.16M
Net Non-Operating Interest Income (Expense) -$88.49M -$87.49M -$274.07M -$87.10M -$72.66M
Non-Operating Interest Income $5.13M $6.23M $33.59M $7.07M $6.90M
Non-Operating Interest Expense $93.62M $93.72M $307.66M $94.17M $79.56M
Other Income (Expense) $36.86M -$76.73M $38.75M $54.63M $89.72M
Gain on Sale of Security $34.28M -$26.85M $24.01M $58.80M $75.34M
Earnings from Equity Interest $4.08M $21.76M $29.09M $4.01M $15.95M
Special Income (Charges) $0.00 -$69.44M – – –
-Less:Write Off $0.00 $69.44M – – –
Other Non-Operating Income (Expenses) -$1.50M -$2.20M -$14.35M -$8.17M -$1.58M
Pretax Profit $81.49M $468.26M $1.32B $355.91M $444.21M
Tax $0.00 $0.00 $0.00 $0.00 $0.00
Net Profit $81.49M $468.26M $1.32B $355.91M $444.21M
Profit from Continuing Operations $81.49M $468.26M $1.32B $355.91M $444.21M
Minority Interests $63.60M $173.57M $553.25M $141.71M $155.99M
Net Income to Parent Company $17.88M $294.69M $770.95M $214.21M $288.22M
Net Income to Common Stockholders $17.88M $294.69M $770.95M $214.21M $288.22M
Basic EPS $0.04 $0.67 $1.79 $0.50 $0.67
Diluted EPS $0.04 $0.67 $1.78 $0.38 $0.67
Dividend Per Share $0.24 $0.24 $0.88 $0.22 $0.22

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $19.82B $19.82B $19.62B $19.62B $19.35B
Total Current Assets $1.76B $1.43B $1.53B $1.53B $1.85B
Cash and Cash Equivalents & Short-Term Investments $1.73B $1.39B $1.49B $1.49B $1.82B
-Cash and Cash Equivalents $811.99M $586.40M $618.70M $618.70M $938.94M
-Short Term Investments $914.45M $801.74M $873.19M $873.19M $876.17M
Receivables $31.47M $27.51M $29.32M $29.32M $28.90M
-Other Receivables $31.47M $27.51M $29.32M $29.32M $28.90M
Other Current Assets $6.66M $10.16M $6.89M $6.89M $5.52M
Total Non-Current Assets $18.06B $18.39B $18.09B $18.09B $17.50B
Investments and Advances $17.07B $17.39B $17.09B $17.09B $16.49B
-Available for Sale Securities $16.81B $17.12B $16.80B $16.80B $16.20B
-Long Term Equity Investment $261.97M $265.70M $289.97M $289.97M $290.96M
Goodwill and Other Intangible Assets $923.54M $924.63M $924.63M $924.63M $924.63M
-Goodwill $923.54M $924.63M $924.63M $924.63M $924.63M
Other Non-Current Assets $62.96M $76.85M $79.29M $79.29M $86.59M
Total Liabilities $10.03B $9.88B $9.91B $9.91B $9.73B
Total Current Liabilities $630.93M $535.68M $636.21M $636.21M $530.80M
Payables $126.85M $112.90M $92.23M $92.23M $118.64M
-Accounts Payable $35.57M $25.48M $19.40M $19.40M $41.42M
-Dividends Payable $91.28M $87.42M $72.83M $72.83M $77.22M
Current Accrued Expenses $107.77M $25.30M $110.82M $110.82M $29.04M
Short-Term Debt and Capital Lease Obligation $380.00M $380.00M $380.00M $380.00M $380.00M
-Current Debt $380.00M $380.00M $380.00M $380.00M $380.00M
Other Current Liabilities $16.32M $17.48M $53.16M $53.16M $3.12M
Total Non-Current Liabilities $9.40B $9.34B $9.27B $9.27B $9.20B
Long Term Debt and Capital Lease Obligation $8.58B $8.58B $8.57B $8.57B $8.57B
-Long Term Debt $8.58B $8.58B $8.57B $8.57B $8.57B
Employee Benefits $713.22M $648.67M $577.87M $577.87M $502.94M
Other Non-Current Liabilities $108.02M $117.79M $120.84M $120.84M $126.94M
Total Equity $9.79B $9.94B $9.71B $9.71B $9.62B
Stockholders' Equity $6.83B $6.89B $6.48B $6.48B $6.41B
Capital Stock $108,000.00 $108,000.00 $106,000.00 $106,000.00 $107,000.00
-Common Stock $108,000.00 $108,000.00 $106,000.00 $106,000.00 $107,000.00
Additional Paid-In Capital $4.38B $4.38B $4.12B $4.12B $4.11B
Retained Earnings $2.46B $2.51B $2.36B $2.36B $2.30B
Less: Treasury Stock $2.72M $2.71M $2.61M $2.61M $2.61M
Minority Interests $2.95B $3.05B $3.24B $3.24B $3.21B

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow $728.46M $718.23M $2.49B $827.15M $702.62M
Net cash flow from continuing operations $728.46M $718.23M $2.49B $827.15M $702.62M
Net Income from Continuing Operations $81.49M $468.26M $1.32B $355.91M $441.21M
Gain/Loss from Continuing Operations -$669.70M -$596.58M -$2.31B -$655.23M -$667.10M
Depreciation & Depletion & Amortization $1.29M $1.17M $3.85M $1.20M $1.28M
Other Non-Cash Items $826.00M $925.16M $3.40B $932.16M $892.36M
Change in Working Capital $86.69M -$80.42M -$17.15M $48.51M -$50.88M
-Change in Receivables -$3.96M $1.81M -$2.36M -$415,000.00 -$1.16M
-Change in Payables and Accrued Expense $90.60M -$90.60M -$4.99M $53.24M -$45.66M
-Change in Other Current Assets $1.01M -$4.91M -$7.45M -$3.31M -$3.05M
-Change in Other Current Liabilities -$954,000.00 $13.28M -$2.35M -$1.01M -$1.01M
Net cash flow from investing -$229.72M -$477.87M -$1.61B -$847.80M -$958.31M
Net Cash Flow from Continuing Investing Activities -$229.72M -$477.87M -$1.61B -$847.80M -$958.31M
Net Investment Purchase and Sale -$216.19M -$470.17M -$1.36B -$850.08M -$958.99M
Net Other Investing Changes -$317,000.00 -$50.00M -$280.26M -$2.71M $0.00
Financing Cash Flow -$273.15M -$272.67M -$1.19B -$299.60M $562.74M
Net Cash Flow from Continuing Financing Activities -$273.15M -$272.67M -$1.19B -$299.60M $562.74M
Net Common Stock Issuance -$44.64M -$50.10M -$1.23B -$80.54M -$146.49M
Cash Dividends Paid -$104.92M -$104.49M -$378.25M -$94.34M -$95.31M
Net Other Financing Charges -$123.59M -$118.08M -$534.81M -$124.72M -$149.94M
Ending Cash Balance $811.99M $586.40M $618.70M $618.70M $938.94M
Net Change in Cash $225.59M -$32.30M -$310.33M -$320.25M $307.04M
Beginning Cash Balance $586.40M $618.70M $929.03M $938.94M $631.91M
Free Cash Flow $728.46M $718.23M $2.49B $827.15M $702.62M
Net Business Purchase and Sale – – -$74.42M $0.00 -$226,000.00
Net Issuance Payments Of Debt – – $954.48M $0.00 –

Discussion

No comments yet — be the first to weigh in on RPRX.

Leave a comment

Scroll to Top